Global Ophthalmic Viscoelastic Devices Market Assessment, By Product Type [Cohesive Ophthalmic Viscoelastic Devices, Dispersive Ophthalmic Viscoelastic Devices, Viscoadaptive Ophthalmic Viscoelastic Devices, Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices], By Composition [Sodium Hyaluronate, Chondroitin Sulfate, Hydroxypropyl Methylcellulose], By Application [Cataract Surgery, Glaucoma Surgery, Vitreoretinal Surgery, Corneal Transplantation Surgery, Other Applications], By End-user [Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
The global ophthalmic viscoelastic devices market is driven by increasing surgical procedures, rising incidence of chronic diseases, screen time, geriatric population, etc., amongst which diagnosis of eye related disorders are the primary reason for the growth.
Home>Industry Reports>Global Ophthalmic Viscoelastic Devices Market Assessment, Opportunities and Forecast, 2017-2031F
Global ophthalmic viscoelastic devices market size was valued at USD 3.01 billion in 2023 and is expected to reach USD 4.48 billion in 2031, with a CAGR of 5.1% for the forecast period between 2023 and 2031F. The global market for ophthalmic viscoelastic devices is experiencing significant growth due to several key factors, such as the increasing prevalence of eye-related disorders, the growing elderly population, and advancements in ophthalmic devices. Additionally, lifestyle changes, prolonged screen time, and the rising incidence of chronic diseases contribute to more patients with eye disorders, driving the demand for ophthalmic viscoelastic devices.
The ophthalmic viscoelastic devices market is projected to grow substantially, driven by the increasing demand for various surgical procedures, including those related to cataracts, glaucoma, corneal transplantation, and vitreoretinal surgery. The geriatric population is particularly susceptible to vision impairment, further boosting the need for ophthalmic viscoelastic devices. Furthermore, the market is influenced by the prevalence of chronic conditions such as diabetes and hypertension, which are often associated with eye disorders. Technological advancements, government policies supporting healthcare infrastructure, and enhanced availability of medical devices are fueling the market growth. However, challenges such as the risk of a rise in ocular pressure after surgery and the presence of alternative therapies may impede market expansion.
In April 2023, Bausch + Lomb Corporation announced the launch of two viscoelastic devices, StableVisc cohesive ophthalmic viscosurgical device (OVD) and TotalVisc Viscoelastic System, in the United States market. Both the devices contain a mix of sodium hyaluronate and sorbitol, providing a strong physical barrier and delivering increased free radical scavenging capabilities compared to other available ophthalmic viscoelastic devices.
Rising Prevalence of Ophthalmic Disorders
The increasing prevalence of ophthalmic disorders, such as refractive errors, cataracts, diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD), significantly impacts the global ophthalmic viscoelastic devices (OVDs) market. These disorders are on the rise due to factors like unhealthy lifestyles, nutritional deficiency, and longer screen time. The increasing prevalence of these diseases is expected to drive the demand for ophthalmic viscoelastic devices, as these devices are extensively used in ophthalmic surgeries. A WHO factsheet from August 2023 states that 2.2 billion people worldwide suffer from near or far-sightedness. Out of which, 1 billion are affected by blindness from distance vision impairment, including 94 million people with cataracts, 88.4 million with refractive error, 8 million with age-related macular degeneration, 7.7 million with glaucoma, and 3.9 million with diabetic retinopathy. Presbyopia, which affects 826 million people, is the main condition that impairs close vision.
Growing Geriatric Population
Another important aspect that has contributed significantly to the increased need for ophthalmic viscoelastic devices is the aging population. People who are older tend to have comorbid ailments such as chronic illnesses and ophthalmic disorders that affect their eyes. As per WHO, by 2030, one in six people in the world will be 60 years of age or older. By 2030, there will be 1.4 billion over-60s, compared to 1 billion in 2020. By 2050, there will be twice as many people 60 years or older on the planet, i.e., 2.1 billion people. It is projected that the population of 80 years of age or older will quadruple to 426 million by 2050.
Cohesive Ophthalmic Viscoelastic Devices to Dominate
The cohesive ophthalmic viscoelastic devices segment in global ophthalmic viscoelastic devices is expected to dominate during the forecast period. Cohesive ophthalmic viscoelastic devices are being used extensively as they offer advantages such as high viscosity, which increases the stability of the surgical environment, and high cohesion, which eases surgical removal. It stabilizes structures and enables pressurization of the space they occupy. The growing prevalence of cataracts and technological advancements in ophthalmic viscoelastic devices are reasons for the dominance of the cohesive ophthalmic viscoelastic devices segment. Market players are expanding their product portfolio to gain a competitive edge in this product category.
North America is Expected to Dominate
With high investment in research and development activities, technological advancements by key players, and advanced healthcare infrastructure in countries, like the United States and Canada, the region is expected to dominate the market with the highest value share. Supportive government initiatives for managing the growing number of ophthalmic surgeries are embracing the growth of the market in the region. High disposable income and preference for ophthalmic treatments of eye problems, along with the presence of key players, are contributing to the dominance of North America in the ophthalmic viscoelastic devices market.
Future Market Scenario
Growth in healthcare infrastructure in developing countries and efforts to reduce the burden of ophthalmic disorders like integrated people-centered eye care (IPEC) by WHO is expected to set a positive trend for the market. Key market players focus on developing innovative products and expanding their market presence. In terms of regional growth, Asia-Pacific market is expected to experience a robust CAGR, driven by its sizable population, rising disposable income, and growing patient awareness of the need for eye care. In the future, surgeons might be able to carry out more intricate and accurate surgeries, and viscoelastic devices might be utilized to operate a wider range of ocular ailments.
Report Scope
“Ophthalmic Viscoelastic Devices Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global ophthalmic viscoelastic devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031F |
|
Projected Growth Rate |
CAGR of 5.1% between 2024 and 2031F |
|
Revenue Forecast in 2031 |
USD 4.48 Billion |
|
Units |
Revenue in USD Billion |
|
Segments Covered |
Product Type, Composition, Application, End-user |
|
Regions Covered |
North America, Europe, Asia-Pacific, Middle East, and Africa, South America |
|
Key Companies Profiled |
Alcon Laboratories, Inc., Carl Zeiss Meditec AG, Rumex International Corporation, Altacor Limited, Bausch & Lomb Incorporated, Novartis International AG, Johnson & Johnson Surgical Vision Inc., CVC Capital Partners SICAV- FIS SA, Eyekon Medical Inc., Bohus BioTech AB, Beaver Visitec Limited, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, global ophthalmic viscoelastic devices market has been segmented into the following categories:
· By Product Type
o Cohesive Ophthalmic Viscoelastic Devices
o Dispersive Ophthalmic Viscoelastic Devices
o Viscoadaptive Ophthalmic Viscoelastic Devices
o Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
· By Composition
o Sodium Hyaluronate
o Chondroitin Sulfate
o Hydroxypropyl Methylcellulose
· By Application
o Cataract Surgery
o Glaucoma Surgery
o Vitreoretinal Surgery
o Corneal Transplantation Surgery
o Other Applications
· By End-user
o Eye Clinics
o Ambulatory Surgical Centers
o Academic and Research Institutes
o Others
· By Region
o North America
o Europe
o Asia Pacific
o South America
o Middle East & Africa
Key Players Landscape and Outlook
The global ophthalmic viscoelastic devices market consists of market players like Bausch & Lomb Incorporated, Alcon Laboratories, Inc., Johnson & Johnson Surgical Vision Inc., and others, who are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products.
For instance, In January 2022, Glaukos Corporation announced that it received 510(k) clearance from the United States Food and Drug Administration (FDA) for its viscoelastic device named ‘iPRIME Viscodelivery System’. Glaukos is an ophthalmic medtech and pharmaceutical company dedicated to developing novel therapies for managing glaucoma, retinal diseases, and corneal disorders. iPRIME Viscodelivery System is a single-use, sterile, minimally-invasive device for delivering viscoelastic fluid during ophthalmic surgeries.
Key Players Operating in the Global Ophthalmic Viscoelastic Devices Market are:
· Alcon Laboratories, Inc.
· Carl Zeiss Meditec AG
· Rumex International Corporation
· Altacor Limited
· Bausch & Lomb Incorporated
· Novartis International AG
· Johnson & Johnson Surgical Vision Inc.
· CVC Capital Partners SICAV- FIS SA
· Eyekon Medical Inc.
· Bohus BioTech AB
· Beaver Visitec Limited
· Neu Micromed International Pvt. Ltd.
· Rayner Intraocular Lenses Limited
Markets and Data’s reports answer the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global ophthalmic viscoelastic devices market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Ophthalmic Viscoelastic Devices Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.By Value
4.1.2.By Volume
4.2. By Product Type
4.2.1.Cohesive Ophthalmic Viscoelastic Devices
4.2.2.Dispersive Ophthalmic Viscoelastic Devices
4.2.3.Viscoadaptive Ophthalmic Viscoelastic Devices
4.2.4.Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
4.3. By Composition
4.3.1.Sodium Hyaluronate
4.3.2.Chondroitin Sulfate
4.3.3.Hydroxypropyl Methylcellulose
4.4. By Application
4.4.1.Cataract Surgery
4.4.2.Glaucoma Surgery
4.4.3.Vitreoretinal Surgery
4.4.4.Corneal Transplantation Surgery
4.4.5.Other Applications
4.5. By End-user
4.5.1.Hospitals
4.5.2.Eye Clinics
4.5.3.Ambulatory Surgical Centers
4.5.4.Academic and Research Institutes
4.5.5.Others
4.6. By Region
4.6.1.North America
4.6.2.Europe
4.6.3.Asia Pacific
4.6.4.South America
4.6.5.Middle East & Africa
4.7. By Company Market Share (%), 2023
5. Global Ophthalmic Viscoelastic Devices Market, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2.By Product Type
5.1.2.1. Cohesive Ophthalmic Viscoelastic Devices
5.1.2.2. Dispersive Ophthalmic Viscoelastic Devices
5.1.2.3. Viscoadaptive Ophthalmic Viscoelastic Devices
5.1.2.4. Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
5.1.3.By Composition
5.1.3.1. Sodium Hyaluronate
5.1.3.2. Chondroitin Sulfate
5.1.3.3. Hydroxypropyl Methylcellulose
5.1.4.By Application
5.1.4.1. Cataract Surgery
5.1.4.2. Glaucoma Surgery
5.1.4.3. Vitreoretinal Surgery
5.1.4.4. Corneal Transplantation Surgery
5.1.4.5. Other Applications
5.1.5.By End-user
5.1.5.1. Hospitals
5.1.5.2. Eye Clinics
5.1.5.3. Ambulatory Surgical Centers
5.1.5.4. Academic and Research Institutes
5.1.5.5. Others
5.1.6.United States*
5.1.6.1. Market Size & Forecast
5.1.6.1.1. By Value
5.1.6.1.2. By Volume
5.1.6.2. By Product Type
5.1.6.2.1. Cohesive Ophthalmic Viscoelastic Devices
5.1.6.2.2. Dispersive Ophthalmic Viscoelastic Devices
5.1.6.2.3. Viscoadaptive Ophthalmic Viscoelastic Devices
5.1.6.2.4. Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
5.1.6.3. By Composition
5.1.6.3.1. Sodium Hyaluronate
5.1.6.3.2. Chondroitin Sulfate
5.1.6.3.3. Hydroxypropyl Methylcellulose
5.1.6.4. By Application
5.1.6.4.1. Cataract Surgery
5.1.6.4.2. Glaucoma Surgery
5.1.6.4.3. Vitreoretinal Surgery
5.1.6.4.4. Corneal Transplantation Surgery
5.1.6.4.5. Other Applications
5.1.6.5. By End-user
5.1.6.5.1. Hospitals
5.1.6.5.2. Eye Clinics
5.1.6.5.3. Ambulatory Surgical Centers
5.1.6.5.4. Academic and Research Institutes
5.1.6.5.5. Others
5.1.7.Canada
5.1.8.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. South America
5.3.1.Brazil
5.3.2.Argentina
5.4. Asia-Pacific
5.4.1.India
5.4.2.China
5.4.3.Japan
5.4.4.Australia
5.4.5.Vietnam
5.4.6.South Korea
5.4.7.Indonesia
5.4.8.Philippines
5.5. Middle East & Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.Israel
5.5.4.South Africa
6. Market Mapping, 2023
6.1. By Product Type
6.2. By Composition
6.3. By Application
6.4. By End-user
6.5. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis – Volume and Value
7.3. Supply/Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat from New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges, Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Johnson & Johnson Surgical Vision Inc.
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.2. Alcon Laboratories, Inc.
13.3. Carl Zeiss Meditec AG
13.4. Rumex International Corporation
13.5. Altacor Limited
13.6. Bausch & Lomb Incorporated
13.7. Novartis International AG
13.8. CVC Capital Partners SICAV- FIS SA
13.9. Eyekon Medical Inc.
13.10. Bohus BioTech AB
13.11. Beaver Visitec Limited
13.12. Neu Micromed International Pvt. Ltd.
13.13. Rayner Intraocular Lenses Limited
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 4. Global Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 5. Global Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 6. Global Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 7. Global Ophthalmic Viscoelastic Devices Market Share (%), By Region, 2017-2031F
Figure 8. North America Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 10. North America Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 11. North America Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 12. North America Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 13. North America Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 14. North America Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
Figure 15. United States Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 17. United States Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 18. United States Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 19. United States Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 20. United States Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 23. Canada Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 24. Canada Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 25. Canada Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 26. Canada Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 29. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 30. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 31. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 32. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 35. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 36. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 37. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 38. Europe Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
Figure 40. Germany Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 42. Germany Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 43. Germany Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 44. Germany Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 45. Germany Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 46. France Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 48. France Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 49. France Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 50. France Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 51. France Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 54. Italy Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 55. Italy Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 56. Italy Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 57. Italy Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 60. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 61. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 62. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 66. Russia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 67. Russia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 68. Russia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 69. Russia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 72. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 73. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 74. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 78. Spain Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 79. Spain Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 80. Spain Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 81. Spain Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 84. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 85. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 86. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 87. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 90. Poland Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 91. Poland Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 92. Poland Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 93. Poland Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 94. South America Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 96. South America Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 97. South America Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 98. South America Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 99. South America Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 100. South America Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 103. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 104. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 105. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 106. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 109. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 110. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 111. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 112. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 115. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 116. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 117. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
Figure 120. India Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 122. India Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 123. India Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 124. India Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 125. India Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 126. China Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 128. China Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 129. China Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 130. China Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 131. China Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 134. Japan Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 135. Japan Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 136. Japan Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 137. Japan Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 140. Australia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 141. Australia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 142. Australia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 143. Australia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 146. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 147. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 148. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 152. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 153. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 154. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 155. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 158. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 159. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 160. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 164. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 165. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 166. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 167. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 170. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 171. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 172. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 177. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 178. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 179. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 183. UAE Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 184. UAE Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 185. UAE Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 186. UAE Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
Figure 189. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
Figure 190. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
Figure 191. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
Figure 192. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
Figure 193. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Composition Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What are the regions covered in the final report of global ophthalmic viscoelastic devices market?
What are the major drivers influencing the growth of global ophthalmic viscoelastic devices market?
Who are the key players operating in global ophthalmic viscoelastic devices market?
What is the market size and growth rate of global ophthalmic viscoelastic devices market?
See Related Reports
Global Coffee Market Assessment, Opportunities and Forecast, 2017-2031F
Global coffee market is expected to experience growth due to consumers’ increasing preference for organic and premium coffee that offers freshness, superior quality of beans and roasts, and unique flavor profile. Additionally, the product innovation,....Read More
Published on
July 2024
4,500
Global Home Theater System Market Assessment, Opportunities and Forecast, 2017-2031F
Global home theater system market is expected to experience growth due to technological advancements, increasing disposable incomes, rising demand for high-definition content, integration with smart home systems, and the surge in streaming services p....Read More
Published on
July 2024
4,500
Global Baby Food Market Assessment, Opportunities and Forecast, 2017-2031F
Global baby food market is expected to experience growth due to factors such as consumers’ increasing awareness of the nutrients which are essential for babies development and introduction of wide variety of baby foods in the market from milk powders....Read More
Published on
July 2024
4,500
Global Isoflavones Market Assessment, Opportunities and Forecast, 2017-2031F
Global isoflavones market is expected to experience growth due to increasing consumer health awareness, rising demand for functional foods and nutraceuticals, advancements in extraction technologies, and expanding applications in cosmetics, pharmaceu....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
